Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Biosimilars Advisory Service : Physician Perspectives on Granulocyte Colony-Stimulating Factors and Monoclonal Antibodies in Oncology | US | 2015
In recent years, biosimilars of epoetin alfa and filgrastim have been approved and launched in major markets. Uptake of these products among oncologists is increasing, driven by payers and…
Biosimilars Advisory Service : Physician Perspectives on Erythropoiesis-Stimulating Agents, Insulin, and Human Growth Hormone | US/EU5/Japan | 2015
Nephrologists and endocrinologists in Europe have had the opportunity to use biosimilar erythropoiesis-stimulating agents (ESAs) and human growth hormone (hGH), respectively, for several years, but…
Biosimilars Advisory Service : Physician Perspectives on Biologics in Rheumatology and Gastroenterology | US/EU5/Japan | 2015
Biologics prescribed by rheumatologists and gastroenterologists are among the most commercially successful biopharmaceutical products in the world. These biologics are a prime target for biosimilar…
Biosimilars Advisory Service : Acceptance of Biosimilars Across Physician Specialties | US,France and Germany | 2015
Gaining physician confidence is critical to securing a meaningful position in developed markets; therefore, understanding their concerns about biosimilar products should be an important part of…
Biosimilars Advisory Service : US and EU Payer Perspectives on Biosimilars | US/EU | 2015
How payers choose to adopt and promote biosimilars will be highly impactful in determining the future commercial opportunity for biosimilars in the United States and across Europe. We conducted…
The Impact of Biosimilars in NHL, Breast Cancer, and Colorectal Cancer | Physician & Payer Forum | Brazil and Mexico | 2015
Physician and Payer Expectations for Changes in Treatment Algorithms Monoclonal antibodies (MAbs) have become the standard of care in the treatment of non-Hodgkin’s lymphoma (NHL), colorectal…
Biosimilars Advisory Service : Global Biosimilars Markets – Regulations, Pipelines, and Major Players | G7 | 2015
Latest update: Global Biosimilars Pipeline updated on 31 July 2015 The biosimilars market is not all about the United States, Europe, and Japan. Although these developed markets account for 75%…
